Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 28.6.2021B.Braun Melsungen AG (BME)80553Braunol (sol der 1x1000 ml (fľ.PE))25.6.2021R
 24.6.2021Laboratoires THEA (LHH-1)91093SPERSALLERG (int opo 1x10 ml (fľ.HDPE))25.6.2021R
 24.6.2021GALVEX, spol. s r.o. (GVX)89611Indometacin 100 Galvex (sup 10x100 mg (strip PVC/LDPE))24.6.2021O
 24.6.2021ratiopharm GmbH (RAT)33681Simvastatin-ratiopharm 20 mg (tbl flm 30x20 mg (blis.PVC/PE/PVDC/Al))28.7.2021R
 24.6.2021ratiopharm GmbH (RAT)36306Fentanyl ratiopharm 50 µg/h (emp tdm 5x50 µg/1 h (vre.papier/PE/Al/surlyn))14.7.2021R
 24.6.2021ratiopharm GmbH (RAT)36310Fentanyl ratiopharm 75 µg/h (emp tdm 5x75 µg/1 h (vre.papier/PE/Al/surlyn))14.7.2021R
 23.6.2021Mylan IRE Healthcare Limited (MYR)59810Fraxiparine Forte 19 000 IU (anti-Xa)/1 ml (sol inj 10x1,0 ml/19 KU (striek.inj.skl.napl.))24.6.2021O
 23.6.2021Mylan IRE Healthcare Limited (MYR)96986Fraxiparine 5 700 IU (anti Xa)/0,6 ml (sol inj 10x0,6 ml/5,7 KU (striek.inj.skl.napl.))24.6.2021R
 23.6.2021Mylan IRE Healthcare Limited (MYR)96988Fraxiparine 9 500 IU (anti-Xa)/1 ml (sol inj 10x1 ml/9,5 KU (striek.inj.skl.napl.))24.6.2021O
 23.6.2021Merck Europe B.V. (MCK-NL)28604Cetrotide 0,25 mg prášok a rozpúšťadlo na injekčný roztok (plv iol 7x0,25 mg + 1 ml solv. (liek.inj.skl.+striek.inj.napl.skl.))22.6.2021R
 22.6.2021GlaxoSmithKline Trading Services Limited (GAG-IRL-3)17156Augmentin 625 mg (tbl flm 21x625 mg (blis.Al/PVC/PVDC))28.6.2021R
 21.6.2021Pfizer Europe MA EEIG (PFI-BE-3)76456BeneFIX 500 IU prášok a rozpúšťadlo na injekčný roztok (plv iol 1x500 IU+1x5 ml solv.(liek.inj.skl.+striek.napl.skl.+set inj.))30.7.2021R
 21.6.2021Pfizer Europe MA EEIG (PFI-BE-3)76455BeneFIX 250 IU prášok a rozpúšťadlo na injekčný roztok (plv iol 1x250 IU+1x5 ml solv.(liek.inj.skl.+striek.napl.skl.+set inj.))30.6.2021R
 21.6.2021GlaxoSmithKline Trading Services Limited (GAG-IRL-3)27957Flixotide Diskus 100 µg (plv inh 1x60 dávok (blis.+inhalátor))21.6.2021R
 21.6.2021Mylan IRE Healthcare Limited (MYR)59503LIPANTHYL SUPRA 160 mg (tbl flm 30x160 mg (blis.PVC/PE/PVDC/Al))23.6.2021R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)